OGC
TMO icon

Oak Grove Capital’s Thermo Fisher Scientific TMO Stock Holding History

Oak Grove Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$583K Sell
1,162
-82
-7% -$39.4K 0.03% 84
2026
Q1 		$611K Hold
1,244
– – 0.05% 66
2025
Q4 		$721K Sell
1,244
-200
-14% -$113K 0.09% 53
2025
Q3 		$700K Sell
1,444
-1,750
-55% -$815K 0.1% 50
2025
Q2 		$1.3M Sell
3,194
-8,885
-74% -$3.71M 0.21% 42
2025
Q1 		$6.01M Sell
12,079
-256
-2% -$139K 1.25% 18
2024
Q4 		$6.42M Sell
12,335
-4
-0% -$2.2K 0.96% 23
2024
Q3 		$7.63M Buy
12,339
+6
+0% +$3.55K 1.25% 17
2024
Q2 		$6.82M Sell
12,333
-300
-2% -$172K 1.24% 16
2024
Q1 		$7.34M Sell
12,633
-100
-0.8% -$56.1K 1.48% 17
2023
Q4 		$6.76M Buy
12,733
+1,000
+9% +$484K 1.8% 18
2023
Q3 		$5.94M Sell
11,733
-100
-0.8% -$53.3K 2.06% 17
2023
Q2 		$6.17M Buy
11,833
+1,360
+13% +$734K 2.11% 16
2023
Q1 		$6.04M Buy
10,473
+146
+1% +$82.3K 2.47% 14
2022
Q4 		$5.69M Sell
10,327
-1,525
-13% -$808K 2.86% 13
2022
Q3 		$6.01M Buy
11,852
+2,360
+25% +$1.32M 2.03% 15
2022
Q2 		$5.16M Sell
9,492
-620
-6% -$341K 1.68% 18
2022
Q1 		$5.97M Buy
10,112
+50
+0.5% +$28.7K 1.21% 24
2021
Q4 		$6.71M Sell
10,062
-193
-2% -$121K 1.17% 23
2021
Q3 		$5.86M Sell
10,255
-50
-0.5% -$27.4K 1.26% 23
2021
Q2 		$5.2M Buy
10,305
+550
+6% +$260K 1.16% 25
2021
Q1 		$4.45M Sell
9,755
-150
-2% -$71.6K 1.24% 29
2020
Q4 		$4.61M Buy
9,905
+3,015
+44% +$1.41M 1.51% 26
2020
Q3 		$3.04M Sell
6,890
-90
-1% -$37.2K 1.44% 25
2020
Q2 		$2.53M Buy
+6,980
New +$2.34M 1.52% 20

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Oak Grove Capital's TMO Position: Q2 2026 in Review

Oak Grove Capital reduced its Thermo Fisher Scientific (TMO) stake by 6.6% in Q2 2026, selling an estimated $39.4K and leaving 1,162 shares worth $583K. The position accounts for 0.03% of the portfolio, ranked #84.

Oak Grove Capital first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $7.63M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Oak Grove Capital held 1,162 shares of Thermo Fisher Scientific worth $583K as of Q2 2026.
  • Oak Grove Capital sold 82 Thermo Fisher Scientific shares in Q2 2026, an estimated $39.4K.
  • Thermo Fisher Scientific made up 0.03% of Oak Grove Capital's portfolio in Q2 2026, its #84 holding.
  • Oak Grove Capital first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • Oak Grove Capital's Thermo Fisher Scientific position peaked at $7.63M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Oak Grove Capital's 13F filing for Q2 2026, filed 13 Aug 2026.